Evotec SE (EVT.DE)
EUR 8.5
(-4.23%)
EUR 8.5
(-4.23%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 477.11 Million EUR | -2.69% |
| 2022 | 490.29 Million EUR | 6.05% |
| 2021 | 462.3 Million EUR | 0.08% |
| 2020 | 461.95 Million EUR | 4.43% |
| 2019 | 442.36 Million EUR | 668.72% |
| 2018 | 57.54 Million EUR | 168.15% |
| 2017 | 21.46 Million EUR | 197.07% |
| 2016 | 7.22 Million EUR | -17.25% |
| 2015 | 8.73 Million EUR | 6.65% |
| 2014 | 8.18 Million EUR | 58371.43% |
| 2013 | 14 Thousand EUR | -99.66% |
| 2012 | 4.17 Million EUR | 77.03% |
| 2011 | 2.36 Million EUR | -33.18% |
| 2010 | 3.53 Million EUR | -9.18% |
| 2009 | 3.88 Million EUR | -53.66% |
| 2008 | 8.39 Million EUR | -14.58% |
| 2007 | 9.82 Million EUR | 20.95% |
| 2006 | 8.12 Million EUR | 46.92% |
| 2005 | 5.52 Million EUR | 250.57% |
| 2004 | 1.57 Million EUR | 190.39% |
| 2003 | 543.11 Thousand EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| 2001 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 472.73 Million EUR | 53.67% |
| 2024 Q2 | 428.18 Million EUR | -9.42% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 Q4 | 477.11 Million EUR | 7.35% |
| 2023 Q3 | 444.45 Million EUR | 2570.84% |
| 2023 Q2 | 16.64 Million EUR | 0.0% |
| 2023 FY | 477.11 Million EUR | -2.69% |
| 2022 FY | 490.29 Million EUR | 6.05% |
| 2022 Q1 | 467.92 Million EUR | 1.22% |
| 2022 Q3 | 477.98 Million EUR | 1.97% |
| 2022 Q4 | 490.29 Million EUR | 2.58% |
| 2022 Q2 | 468.74 Million EUR | 0.18% |
| 2021 Q3 | 451.25 Million EUR | 0.51% |
| 2021 Q1 | 486.93 Million EUR | 5.41% |
| 2021 FY | 462.3 Million EUR | 0.08% |
| 2021 Q2 | 448.94 Million EUR | -7.8% |
| 2021 Q4 | 462.3 Million EUR | 2.45% |
| 2020 Q3 | 425.73 Million EUR | -8.68% |
| 2020 FY | 461.95 Million EUR | 4.43% |
| 2020 Q1 | 437.82 Million EUR | -1.03% |
| 2020 Q2 | 466.21 Million EUR | 6.49% |
| 2020 Q4 | 461.95 Million EUR | 8.51% |
| 2019 Q3 | 422.85 Million EUR | 3.37% |
| 2019 Q2 | 409.06 Million EUR | 155.51% |
| 2019 FY | 442.36 Million EUR | 668.72% |
| 2019 Q4 | 442.36 Million EUR | 4.61% |
| 2019 Q1 | 160.09 Million EUR | 178.21% |
| 2018 FY | 57.54 Million EUR | 168.15% |
| 2018 Q2 | 24.29 Million EUR | 20.13% |
| 2018 Q3 | 50.29 Million EUR | 106.96% |
| 2018 Q1 | 20.22 Million EUR | -5.75% |
| 2018 Q4 | 57.54 Million EUR | 14.43% |
| 2017 Q3 | 5.8 Million EUR | -11.06% |
| 2017 FY | 21.46 Million EUR | 197.07% |
| 2017 Q1 | 6.87 Million EUR | -4.78% |
| 2017 Q2 | 6.53 Million EUR | -5.07% |
| 2017 Q4 | 21.46 Million EUR | 269.49% |
| 2016 FY | 7.22 Million EUR | -17.25% |
| 2016 Q4 | 7.22 Million EUR | -3.8% |
| 2016 Q3 | 7.5 Million EUR | -4.72% |
| 2016 Q2 | 7.88 Million EUR | -4.8% |
| 2016 Q1 | 8.27 Million EUR | -5.18% |
| 2015 Q1 | 8.71 Million EUR | 6.51% |
| 2015 FY | 8.73 Million EUR | 6.65% |
| 2015 Q3 | 8.9 Million EUR | 2.58% |
| 2015 Q4 | 8.73 Million EUR | -1.91% |
| 2015 Q2 | 8.67 Million EUR | -0.49% |
| 2014 Q3 | 4.32 Million EUR | 24.02% |
| 2014 Q4 | 8.18 Million EUR | 89.18% |
| 2014 FY | 8.18 Million EUR | 58371.43% |
| 2014 Q1 | 991 Thousand EUR | 6978.57% |
| 2014 Q2 | 3.48 Million EUR | 252.07% |
| 2013 Q1 | 4.14 Million EUR | -0.69% |
| 2013 Q3 | 4.05 Million EUR | -1.1% |
| 2013 Q2 | 4.1 Million EUR | -1.11% |
| 2013 FY | 14 Thousand EUR | -99.66% |
| 2013 Q4 | 14 Thousand EUR | -99.66% |
| 2012 FY | 4.17 Million EUR | 77.03% |
| 2012 Q2 | 5.31 Million EUR | 23.35% |
| 2012 Q4 | 4.17 Million EUR | -1.07% |
| 2012 Q1 | 4.31 Million EUR | 82.71% |
| 2012 Q3 | 4.22 Million EUR | -20.61% |
| 2011 Q1 | 3.01 Million EUR | -14.58% |
| 2011 Q3 | 3 Million EUR | -0.03% |
| 2011 Q4 | 2.36 Million EUR | -21.39% |
| 2011 FY | 2.36 Million EUR | -33.18% |
| 2011 Q2 | 3 Million EUR | -0.46% |
| 2010 Q4 | 3.53 Million EUR | 15.88% |
| 2010 FY | 3.53 Million EUR | -9.18% |
| 2010 Q3 | 3.04 Million EUR | -0.78% |
| 2010 Q2 | 3.07 Million EUR | -17.51% |
| 2010 Q1 | 3.72 Million EUR | -4.24% |
| 2009 Q3 | 7.58 Million EUR | 1.74% |
| 2009 Q2 | 7.45 Million EUR | -9.56% |
| 2009 Q1 | 8.24 Million EUR | -1.81% |
| 2009 FY | 3.88 Million EUR | -53.66% |
| 2009 Q4 | 3.88 Million EUR | -48.71% |
| 2008 FY | 8.39 Million EUR | -14.58% |
| 2008 Q2 | 10.57 Million EUR | 0.0% |
| 2008 Q4 | 8.39 Million EUR | -14.95% |
| 2008 Q3 | 9.86 Million EUR | -6.7% |
| 2007 Q3 | 4.91 Million EUR | 0.0% |
| 2007 FY | 9.82 Million EUR | 20.95% |
| 2007 Q4 | 10.39 Million EUR | 111.4% |
| 2006 Q1 | 2.25 Million EUR | -8.07% |
| 2006 Q3 | 2.76 Million EUR | 2.35% |
| 2006 Q4 | 9.24 Million EUR | 233.89% |
| 2006 FY | 8.12 Million EUR | 46.92% |
| 2006 Q2 | 2.7 Million EUR | 19.82% |
| 2005 Q1 | 2.01 Million EUR | 27.61% |
| 2005 Q4 | 2.45 Million EUR | 0.0% |
| 2005 FY | 5.52 Million EUR | 250.57% |
| 2005 Q2 | 1.92 Million EUR | -4.59% |
| 2004 Q4 | 1.57 Million EUR | 0.0% |
| 2004 FY | 1.57 Million EUR | 190.39% |
| 2004 Q2 | 1.47 Million EUR | 13.85% |
| 2004 Q1 | 1.29 Million EUR | 138.66% |
| 2003 Q4 | 543.11 Thousand EUR | 0.0% |
| 2003 FY | 543.11 Thousand EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| 2001 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| MPH Health Care AG | 8.33 Million EUR | -5625.344% |
| Apontis Pharma AG | 6 Million EUR | -7851.867% |
| Dermapharm Holding SE | 950.7 Million EUR | 49.815% |
| MERCK Kommanditgesellschaft auf Aktien | 8.84 Billion EUR | 94.606% |
| PharmaSGP Holding SE | 65.37 Million EUR | -629.864% |
| SynBiotic SE | 2.89 Million EUR | -16389.41% |